Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Critical Reviews in Oncology/Hematology|July 6, 2025
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancerGiuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
Frontiers in Oncology|August 30, 2024
REThinking the role of the RET oncogene in breast cancerGiuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
Blood|October 31, 2002
CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytesLuisa Granziero, Paola Circosta, Cristina Scielzo, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistanceSilvia Rita Vitale, Federica Martorana, Stefania Stella, et al.
Thrombosis Research|September 5, 2020
Genetic and molecular evidence for complement dysregulation in patients with HELLP syndromeMario Bazzan, Tullia Todros, Silvana Tedeschi, et al.
Anticancer Research|September 4, 2020
Second-line Dasatinib Therapy Improved Compliance and Deep Molecular Responses in Imatinib-intolerant Chronic Myeloid Leukemia PatientsUros Markovic, Anna Bulla, Salvatore Leotta, et al.
Haematologica|December 11, 2025
Is Bruton tyrosine kinase a potential target to treat mast cell neoplasms? Systemic mastocytosis associated with chronic lymphoid leukemia successfully treated with acalabrutinib monotherapy: a case report and review of the literatureManlio Fazio, Chiara Elena, Jacqueline Ferrari, et al.
Frontiers in Pharmacology|April 8, 2026
Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIsMichele Massimino, Elena Tirrò, Chiara Romano, et al.
Cancer Management and Research|April 12, 2022
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern SicilyStefania Stella, Silvia Rita Vitale, Federica Martorana, et al.
Journal of Clinical Medicine|December 10, 2021
Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic CellsMichele Massimino, Paolo Vigneri, Stefania Stella, et al.
Pageof 9